# A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors

> **NCT05609019** · PHASE1 · UNKNOWN · sponsor: **CSPC Ouyi Pharmaceutical Co., Ltd.** · enrollment: 139 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** SYHX2005

## Key facts

- **NCT ID:** NCT05609019
- **Lead sponsor:** CSPC Ouyi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12
- **Primary completion:** 2024-12
- **Final completion:** 2025-12
- **Target enrollment:** 139 (ESTIMATED)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05609019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05609019, "A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05609019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*